BAY 2416964
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BAY 2416964, covering 2025-02-10 to 2025-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Learn How Safe the Study Drug BAY 2416964 (AhR Inhibitor) in Combination With the Treatment Pembrolizumab is, How This Combination Affects the Body, the Maximum Amount That Can be Given, How it Moves Into, Through and Out of the Body and Its Action Against Advanced Solid Cancers in Adults [Phase 1]